InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Discover the complete record of transactions filed by Dukes Iain D.. Director active across 3 companies, notably Iovance Biotherapeutics, INC.. In total, 5 reports have been recorded. Split: 2 buys · 0 sell. Total volume traded: €331k. History available since 23 November 2022. The latest transaction was disclosed on 20 February 2024 (Acquisition). Regulator: SEC (Form 4). All data is accessible without signup.
5 of 5 declarations